Glycemic Control, Diabetic Complications, and Risk of Dementia in Patients With Diabetes: Results From a Large U.K. Cohort Study
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Type 2 diabetes is an established risk factor for dementia. However, the roles of glycemic control and diabetic complications in the development of dementia have been less well substantiated. This large-scale cohort study aims to examine associations of longitudinal HbA1c levels and diabetic complications with the risk of dementia incidence among patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Data of eligible patients with diabetes, aged ≥50 years in the U.K. Clinical Practice Research Datalink from 1987 to 2018, were analyzed. Time-varying Cox regressions were used to estimate adjusted hazard ratios (HRs) and 95% CIs for dementia risk. RESULTS: Among 457,902 patients with diabetes, 28,627 (6.3%) incident dementia cases were observed during a median of 6 years’ follow-up. Patients with recorded hypoglycemic events or microvascular complications were at higher risk of dementia incidence compared with those without such complications (HR 1.30 [95% CI 1.22–1.39] and 1.10 [1.06–1.14], respectively). The HbA1c level, modeled as a time-varying exposure, was associated with increased dementia risk (HR 1.08 [95% CI 1.07–1.09] per 1% HbA1c increment) among 372,287 patients with diabetes with postdiagnosis HbA1c records. Similarly, a higher coefficient of variation of HbA1c during the initial 3 years of follow-up was associated with higher subsequent dementia risk (HR 1.03 [95% CI 1.01–1.04] per 1-SD increment). CONCLUSIONS: Higher or unstable HbA1c levels and the presence of diabetic complications in patients with type 2 diabetes are associated with increased dementia risk. Effective management of glycemia might have a significant role in maintaining cognitive health among older adults with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430 · cited 1×
“For instance, there is little information on education level and on physical/social activities in CPRD, which are known risk factors for dementia (3,39).”
BackgroundRetracted2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667 · cited 3×
“Practice Research Datalink (CPRD) (19).”
BackgroundInfluentialRisk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · cited 1×
“Moreover, it is acknowledged that most cases of LOD involve mixed brain pathologies (20,21).”
BackgroundBrain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels, G. J., & Despa, F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0048-7 · Cited by 1,454
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Glucose Levels and Risk of Dementia
Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., Haneuse, S., Craft, S., Montine, T. J., Kahn, S. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215740 · Cited by 929
Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
Gudala, K., Bansal, D., Schifano, F., & Bhansali, A. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12087 · Cited by 727
Chatterjee, S., Peters, S. A. E., Woodward, M., Mejia Arango, S., Batty, G. D., Beckett, N., Beiser, A., Borenstein, A. R., Crane, P. K., Haan, M., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1588 · Cited by 711
Launer, L. J., Miller, M. E., Williamson, J. D., Lazar, R. M., Gerstein, H. C., Murray, A. M., Sullivan, M., Horowitz, K. R., Ding, J., Marcovina, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70188-0 · Cited by 574
A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2008) · Diabetes Care · doi:10.2337/dc08-0864 · Cited by 420
An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease
Zhang, J., Chen, C., Hua, S., Liao, H., Wang, M., Xiong, Y., & Cao, F. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.024 · Cited by 376
Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia
Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A. V., Simonsick, E. M., Satterfield, S., Cauley, J. A., Rosano, C., Launer, L. J., Strotmeyer, E. S., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1117 · Cited by 313
Ahmadi-Abhari, S., Guzman-Castillo, M., Bandosz, P., Shipley, M. J., Muniz-Terrera, G., Singh-Manoux, A., Kivimäki, M., Steptoe, A., Capewell, S., O’Flaherty, M., et al. (2017) · BMJ · doi:10.1136/bmj.j2856 · Cited by 301
Self-citation
Research works printed but not linked: 23
- Moran, 2015, Type 2 diabetes mellitus and biomarkers of neurodegeneration, Neurology, 85, 1123, 10.1212/WNL.0000000000001982 · DOI · Paper page
- Li, 2016, Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort, Neurology, 87, 595, 10.1212/WNL.0000000000002950 · DOI · Paper page
- Lee, 2019, Higher dementia incidence in older adults with type 2 diabetes and large reduction in HbA1c, Age Ageing, 48, 838, 10.1093/ageing/afz108 · DOI
- Mukai, 2017, Alternative measures of hyperglycemia and risk of Alzheimer’s disease in the community: the Hisayama study, J Clin Endocrinol Metab, 102, 3002, 10.1210/jc.2017-00439 · DOI
- Gorst, 2015, Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis, Diabetes Care, 38, 2354, 10.2337/dc15-1188 · DOI · Paper page
- Mehta, 2017, Association of hypoglycemia with subsequent dementia in older patients with type 2 diabetes mellitus, J Gerontol A Biol Sci Med Sci, 72, 1110
- Mattishent, 2016, Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis, Diabetes Obes Metab, 18, 135, 10.1111/dom.12587 · DOI · Paper page
- Toledo, 2013, Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre, Brain, 136, 2697, 10.1093/brain/awt188 · DOI · Paper page
- Wilkinson, 2018, Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017, BMJ Open, 8, e022768, 10.1136/bmjopen-2018-022768 · DOI · Paper page
- Pujades-Rodriguez, 2018, The diagnosis, burden and prognosis of dementia: a record-linkage cohort study in England, PLoS One, 13, e0199026, 10.1371/journal.pone.0199026 · DOI · Paper page
- Suh, 2007, Hypoglycemia, brain energetics, and hypoglycemic neuronal death, Glia, 55, 1280, 10.1002/glia.20440 · DOI · Paper page
- Exalto, 2013, Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study, Lancet Diabetes Endocrinol, 1, 183, 10.1016/S2213-8587(13)70048-2 · DOI · Paper page
- Sonnen, 2009, Different patterns of cerebral injury in dementia with or without diabetes, Arch Neurol, 66, 315, 10.1001/archneurol.2008.579 · DOI · Paper page
- Heringa, 2013, Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review, J Cereb Blood Flow Metab, 33, 983, 10.1038/jcbfm.2013.58 · DOI · Paper page
- Schrijvers, 2012, Retinopathy and risk of dementia: the Rotterdam Study, Neurology, 79, 365, 10.1212/WNL.0b013e318260cd7e · DOI
- Rawlings, 2019, The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study, Diabetes Care, 42, 1248, 10.2337/dc19-0120 · DOI · Paper page
- Erus, 2015, Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose, Diabetes Care, 38, 97, 10.2337/dc14-1196 · DOI
- DeVries, 2013, Glucose variability: where it is important and how to measure it, Diabetes, 62, 1405, 10.2337/db12-1610 · DOI · Paper page
- Li, 2017, Visit-to-visit variations in fasting plasma glucose and HbA1c associated with an increased risk of Alzheimer disease: Taiwan Diabetes Study, Diabetes Care, 40, 1210, 10.2337/dc16-2238 · DOI · Paper page
- Wang, 2017, Assessing robustness of hazard ratio estimates to outcome misclassification in longitudinal panel studies with application to Alzheimer’s disease, PLoS One, 12, e0190107, 10.1371/journal.pone.0190107 · DOI
- Donegan, 2017, Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study, Lancet Public Health, 2, e149, 10.1016/S2468-2667(17)30031-2 · DOI · Paper page
- Norton, 2014, Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data, Lancet Neurol, 13, 788, 10.1016/S1474-4422(14)70136-X · DOI · Paper page
- Wheeler, 2017, Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health, Alzheimers Dement (NY), 3, 291, 10.1016/j.trci.2017.04.001 · DOI · Paper page
Cited by
Huang, L., Zhu, M., & Ji, J. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00799-9 · Cited by 46
Zheng, B., Su, B., Ahmadi‐Abhari, S., Kapogiannis, D., Tzoulaki, I., Riboli, E., & Middleton, L. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13349 · Cited by 34
Self-citationJiang, S., Gao, X., Diao, H., Zhang, Y., Lu, G., Liu, X., & Li, Y. (2026) · JMIR mHealth and uHealth · doi:10.2196/70429 · Cited by 6
“Poor glycemic control in T2DM increases the risk of complications such as retinopathy, nephropathy, neuropathy, and cardiovascular diseases, leading to disability and premature mortality [5,6].”
Metadata
- Authors
- Zheng, B., Su, B., Price, G., Tzoulaki, I., Ahmadi-Abhari, S., & Middleton, L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-05-25
- Volume
- 44
- Issue
- 7
- Pages
- 1556-1563
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3165402748
- Cited by
- 104
- References
- 16
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.